Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

Clinical trial NCT03300557 · COMPLETED

Trial details

NCT number: NCT03300557
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atypical Hyperplasia Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia Endometrial Carcinoma FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma

Start date: 2017-11-15
Primary completion: 2023-12-13
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.